These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24549268)

  • 1. The evolution of adenoviral vectors through genetic and chemical surface modifications.
    Capasso C; Garofalo M; Hirvinen M; Cerullo V
    Viruses; 2014 Feb; 6(2):832-55. PubMed ID: 24549268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances and future challenges in Adenoviral vector biology and targeting.
    Campos SK; Barry MA
    Curr Gene Ther; 2007 Jun; 7(3):189-204. PubMed ID: 17584037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-art human adenovirus vectorology for therapeutic approaches.
    Gao J; Mese K; Bunz O; Ehrhardt A
    FEBS Lett; 2019 Dec; 593(24):3609-3622. PubMed ID: 31758807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic strategy to decrease complement activation with adenoviral therapies.
    Gentile CM; Borovjagin AV; Richter JR; Jani AH; Wu H; Zinn KR; Warram JM
    PLoS One; 2019; 14(4):e0215226. PubMed ID: 31026285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging adenoviral vectors for stable correction of genetic disorders.
    Jager L; Ehrhardt A
    Curr Gene Ther; 2007 Aug; 7(4):272-83. PubMed ID: 17969560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
    Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
    Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chromatin in adenoviral vector function.
    Wong CM; McFall ER; Burns JK; Parks RJ
    Viruses; 2013 Jun; 5(6):1500-15. PubMed ID: 23771241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines.
    Weaver EA; Nehete PN; Buchl SS; Senac JS; Palmer D; Ng P; Sastry KJ; Barry MA
    PLoS One; 2009; 4(3):e5059. PubMed ID: 19333387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.
    Murakami M; Ugai H; Belousova N; Pereboev A; Dent P; Fisher PB; Everts M; Curiel DT
    Prostate; 2010 Mar; 70(4):362-76. PubMed ID: 19902467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.
    Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S
    Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.
    Casscells W; Willerson JT
    J Clin Invest; 1995 Jun; 95(6):2425-6. PubMed ID: 7769084
    [No Abstract]   [Full Text] [Related]  

  • 13. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
    Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
    Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineering adenoviral vectors for gene therapy.
    Coughlan L
    Methods Mol Biol; 2014; 1108():23-40. PubMed ID: 24243238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.
    Smith T; Idamakanti N; Kylefjord H; Rollence M; King L; Kaloss M; Kaleko M; Stevenson SC
    Mol Ther; 2002 Jun; 5(6):770-9. PubMed ID: 12027562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting.
    Lu ZH; Dmitriev IP; Brough DE; Kashentseva EA; Li J; Curiel DT
    J Virol; 2020 May; 94(10):. PubMed ID: 32102889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future of adenoviruses in the gene therapy of arthritis.
    Evans CH; Ghivizzani SC; Oligino TA; Robbins PD
    Arthritis Res; 2001; 3(3):142-6. PubMed ID: 11299054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.
    Thirion C; Lochmüller H; Ruzsics Z; Boelhauve M; König C; Thedieck C; Kutik S; Geiger C; Kochanek S; Volpers C; Burgert HG
    Hum Gene Ther; 2006 Feb; 17(2):193-205. PubMed ID: 16454653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of hybrid viral vectors for gene therapy.
    Huang S; Kamihira M
    Biotechnol Adv; 2013; 31(2):208-23. PubMed ID: 23070017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in gene therapy: averting the immune response to adenoviral vectors.
    Ritter T; Lehmann M; Volk HD
    BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.